Fisher & Paykel Healthcare Corp Ltd logo

Fisher & Paykel Healthcare Corp Ltd

NZSE:FPH (New Zealand)   Ordinary Shares
NZ$ 28.36 (-1.7%) May 21
63.17
P/B:
9.42
Market Cap:
NZ$ 16.51B ($ 10.11B)
Enterprise V:
NZ$ 16.76B ($ 10.27B)
Volume:
223.84K
Avg Vol (2M):
469.70K
Also Trade In:
Volume:
223.84K
Avg Vol (2M):
469.70K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Fisher & Paykel Healthcare Corp Ltd ( ) from 1990 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Fisher & Paykel Healthcare stock (NZSE:FPH) PE ratio as of May 22 2024 is 63.17. More Details

Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) PE Ratio (TTM) Chart

To

Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) PE Ratio (TTM) Historical Data

Total 1165
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 13
Fisher & Paykel Healthcare PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-22 63.2 2024-03-15 53.0
2024-05-21 63.2 2024-03-14 54.1
2024-05-20 64.3 2024-03-13 54.7
2024-05-17 64.4 2024-03-12 54.3
2024-05-16 64.7 2024-03-11 54.7
2024-05-15 63.6 2024-03-08 55.4
2024-05-14 64.1 2024-03-07 54.5
2024-05-13 64.3 2024-03-06 55.1
2024-05-10 64.3 2024-03-05 55.0
2024-05-09 63.9 2024-03-04 54.4
2024-05-08 64.9 2024-03-01 55.1
2024-05-07 64.4 2024-02-29 54.6
2024-05-06 64.4 2024-02-28 55.9
2024-05-03 63.6 2024-02-27 55.4
2024-05-02 62.6 2024-02-26 55.5
2024-05-01 62.8 2024-02-23 54.8
2024-04-30 63.4 2024-02-22 53.3
2024-04-29 62.3 2024-02-21 53.2
2024-04-26 61.0 2024-02-20 52.9
2024-04-24 62.1 2024-02-19 53.3
2024-04-23 59.1 2024-02-16 53.7
2024-04-22 58.9 2024-02-15 53.7
2024-04-19 59.2 2024-02-14 53.0
2024-04-18 59.1 2024-02-13 52.9
2024-04-17 59.6 2024-02-12 52.9
2024-04-16 58.8 2024-02-09 54.4
2024-04-15 59.3 2024-02-08 54.7
2024-04-12 58.6 2024-02-07 55.6
2024-04-11 58.6 2024-02-06 55.6
2024-04-10 58.6 2024-02-05 55.6
2024-04-09 57.2 2024-02-02 54.2
2024-04-08 57.2 2024-02-01 53.3
2024-04-05 57.4 2024-01-31 52.7
2024-04-04 56.6 2024-01-30 53.0
2024-04-03 56.6 2024-01-29 52.8
2024-04-02 58.3 2024-01-26 53.3
2024-03-28 57.1 2024-01-25 52.8
2024-03-27 58.8 2024-01-24 53.3
2024-03-26 58.9 2024-01-23 52.9
2024-03-25 58.8 2024-01-22 51.6
2024-03-22 58.0 2024-01-19 52.0
2024-03-21 54.9 2024-01-18 52.1
2024-03-20 53.3 2024-01-17 51.9
2024-03-19 53.3 2024-01-16 52.5
2024-03-18 53.4 2024-01-15 53.4

Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.